Docus: AI-Powered Health Platform
Dr.Andres Jose María Ferreri's second opinion

Dr. Andres Jose María Ferreri

Hematology, Oncology


37 years of experience

Choose for Consultation

Area of expertise


Hematology, Oncology


Hematologic Oncology, Medical Oncology


Lymphoma, Hematologic Cancers

Procedures Performed



Adoptive Cell Therapy


Deputy Director, Division of Onco-Hematological Medicine, Department of Onco-Hematology, San Raffaele Hospital

Milan, Italy. From 2011

Director, Lymphoma Unit, Department of Onco-Hematology, San Raffaele Hospital

Milan, Italy. From 2008

Deputy Director, Medical Oncology Unit, Department of Oncology, San Raffaele Hospital

Milan, Italy. 2007 - 2010

Unit Coordinator, Medical Oncology Unit, San Raffaele Hospital

Milan, Italy. 2004 - 2007

Researcher, Division of Radio-chemotherapy, San Raffaele Hospital

Milan, Italy. 1998 - 2004


MD: University of Buenos Aires



Dr. Andrés José María Ferreri has an impressive work history and scientific expertise in the field of oncology, specifically focusing on lymphomas. His career began with specialized training in clinical oncology at the Central Military Hospital in Buenos Aires, Argentina, from 1987 to 1989. He then pursued further education and training opportunities abroad, including a fellowship at the National Cancer Institute in Milan, Italy, from 1990 to 1994, where he specialized in experimental oncology a


Member, Global Outreach Committee, European Hematology Association

President, Italian Lymphoma Foundation

Member, Scientific Working Group on Lymphomas, European Hematology Association

Member of the Faculty, College of the European School of Oncology

Member of the Presidency Office, Italian Lymphoma Foundation


Recognized as a “World Expert in Lymphoma”. Placed in the top 0.1% of scholars writing about Lymphoma based on 53.807 papers. Ranking position: 9° over 129.972 experts (2020, 2021)

Best Paper Award 2015 of the San Raffaele Scientific Institute: “High doses of antimetabolites followed by high-dose sequential chemoimmunotherapy and autologous stem cell transplantation in patients with systemic B-cell lymphoma and secondary central nervous system involvement: final results of a multicenter phase II trial”. Ferreri AJM, Donadoni G, Cabras MG, et al. Journal of Clinical Oncology


Best Paper Award 2010 of the San Raffaele Scientific Institute: “High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial. Ferreri AJ, Reni M, Foppoli M, et al.


International award “Paul Harris Fellow” of the Rotary International Foundation


Dr. Andrés José María Ferreri has more than 560 publications

You’re only one click away from a life-changing journey

Virtual health assistant powered by AI
350+ world-renowned Doctors